Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michael Morgan

1PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 07, 2024
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells.

Larissa Nassauer, Juliane W Schott, Jennifer Harre

Pageof 1

Frequent Collaborators

1 joint publications

Larissa Nassauer

1 joint publications

Juliane W Schott

1 joint publications

Jennifer Harre

1 joint publications

Athanasia Warnecke

1 joint publications

Melanie Galla

1 joint publications

Axel Schambach

Frequent Collaborators

1 joint publications

Larissa Nassauer

1 joint publications

Juliane W Schott

1 joint publications

Jennifer Harre

1 joint publications

Athanasia Warnecke

Top Related Videos

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on : Mar 16, 2018

9.4K
See more related videos

Top Related Videos

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on : Mar 16, 2018

9.4K
See more related videos